NCF2, MYO1F, S1PR4, and FCN1 as potential noninvasive diagnostic biomarkers in patients with obstructive coronary artery: A weighted gene co‐expression network analysis

Xiangang Mo(Guiyang Medical University), Yue Cai(Wenzhou Medical University), Youcai Deng(Central South University), Rixing Zhan(Army Medical University), Xuqiang Nie(Zunyi Medical University), Saber İmani(Zhejiang Shuren University), Xiaohui Li(Army Medical University), Jun Yan(Beijing Tsinghua Chang Gung Hospital), Wei Liu(Second People’s Hospital of Yibin), Yang Yao(Army Medical University), Bingbo Chen(Shanxi Agricultural University), Shan Lu(Army Medical University), Guorong Dan(Army Medical University)
Journal of Cellular Biochemistry
June 27, 2019
10.1002/jcb.29128
Cited by 45

Related Papers

Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization
|Journal of Neuroinflammation|2020|609
Discovery of (10 <i>R</i> )-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro- <i>2H</i> -8,4-(metheno)pyrazolo[4,3- <i>h</i> ][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations
|Journal of Medicinal Chemistry|2014|587
Macrophage polarization in diabetic wound healing
|Burns & Trauma|2022|208
Transcription Factor Foxo1 Is a Negative Regulator of Natural Killer Cell Maturation and Function
|Immunity|2015|184